Fleet Bioprocessing attending the London Biotechnology Show 2026
Fleet Bioprocessing will be attending the London Biotechnology Show 2026 at ExCeL London 18-19th November.
The London Biotechnology Show brings together biotechnology and pharmaceutical companies, researchers, healthcare organisations, investors and technology providers from across the life sciences sector. The programme covers areas including biopharmaceuticals, diagnostics and precision medicine, gene and cell therapy, biomanufacturing, clinical research and laboratory technologies.
The themes are closely aligned with our work at Fleet Bioprocessing. We provide contract support for Immunoassay Development, Lateral Flow Assay Development and Bioconjugation, together with Complementary Services including Protein Purification, Formulation, Dispensing and Lyophilisation. Our teams can support projects from early feasibility and critical reagent work through assay optimisation, performance verification and transfer to manufacture. Fleet is ISO 9001 and ISO 13485 certified.
Alastair Dent FRSC, Fleet Bioprocessing’s Managing Director & Quality Director, will be attending the event. Alastair has 40 years’ experience in process development and manufacture, with expertise spanning diagnostic assay development, bioconjugation, experimental design, GMP and the development of robust processes for manufacture. He is also an author and consultant in these areas and has contributed to a range of publications, including Bioconjugation: Protein Coupling Techniques for the Biomedical Sciences and The Immunoassay Handbook.
If you are attending the London Biotechology Show and would like to discuss diagnostic development, lateral flow, immunoassays, bioconjugation or related development support, Alastair would be pleased to meet you ExCeL London.
You can also get in touch with us here:
